Transition from film to digital mammography: Impact for breast cancer screening through the national breast and cervical cancer early detection program

American Journal of Preventive Medicine

Volumn 48, Issue 5, 2015, Pages 535-542

  Van Ravesteyn, Nicolien T ^a   Van Lier, Lisanne ^a,b   Schechter, Clyde B ^c   Ekwueme, Donatus U ^d   Royalty, Janet ^d   Miller, Jacqueline W ^d   Near, Aimee M ^e   Cronin, Kathleen A ^f   Heijnsdijk, Eveline A M ^a   Mandelblatt, Jeanne S ^e   De Koning, Harry J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DIGITAL MAMMOGRAPHY; ETHNICITY; FEMALE; FILM MAMMOGRAPHY; FOLLOW UP; HEALTH CARE COST; HEALTH PROGRAM; HISPANIC; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL CARE; MEDICALLY UNINSURED; PREDICTION; RACE; SCREENING TEST; UTERINE CERVIX CANCER; BREAST NEOPLASMS; COMPUTER ASSISTED DIAGNOSIS; EARLY CANCER DIAGNOSIS; FACTUAL DATABASE; MASS COMMUNICATION; MASS SCREENING; MIDDLE AGED; PROCEDURES; UTILIZATION;

ADULT; BREAST NEOPLASMS; DATABASES, FACTUAL; DIAGNOSIS, COMPUTER-ASSISTED; DIFFUSION OF INNOVATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED;

EID: 84928239096     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2014.11.010     Document Type: Article

References (34)

1. A. Jemal, E.P. Simard, and C. Dorell Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and hpv vaccination coverage levels J Natl Cancer Inst 105 3 2013 175 201 10.1093/jnci/djs491
2. D.A. Berry, K.A. Cronin, and S.K. Plevritis Effect of screening and adjuvant therapy on mortality from breast cancer N Engl J Med 353 17 2005 1784 1792 10.1056/NEJMoa050518
3. S.A. Sabatino, R.J. Coates, R.J. Uhler, N. Breen, F. Tangka, and K.M. Shaw Disparities in mammography use among U.S. women aged 40-64 years, by race, ethnicity, income, and health insurance status, 1993 and 2005 Med Care 46 7 2008 692 700 10.1097/MLR.0b013e31817893b1
4. CDC. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). www.cdc.gov/cancer/nbccedp/about.htm.
5. CDC. National Breast and Cervical Cancer Early Detection Program (NBCCEDP). www.cdc.gov/cancer/nbccedp/data/summaries/national-aggregate.htm.
6. E.D. Pisano, C. Gatsonis, and E. Hendrick Diagnostic performance of digital versus film mammography for breast-cancer screening N Engl J Med 353 17 2005 1773 1783 10.1056/NEJMoa052911
7. A.N. Tosteson, N.K. Stout, and D.G. Fryback Cost-effectiveness of digital mammography breast cancer screening Ann Intern Med 148 1 2008 1 10 10.7326/0003-4819-148-1-200801010-00002
8. J. Mandelblatt, C.B. Schechter, W. Lawrence, B. Yi, and J. Cullen The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods J Natl Cancer Inst Monogr 36 2006 47 55 10.1093/jncimonographs/lgj008
9. S.Y. Tan, G.J. van Oortmarssen, H.J. de Koning, R. Boer, and J.D. Habbema The MISCAN-Fadia continuous tumor growth model for breast cancer J Natl Cancer Inst Monogr 36 2006 56 65 10.1093/jncimonographs/lgj009
10. N.T. van Ravesteyn, C.B. Schechter, and A.M. Near Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States Cancer Epidemiol Biomarkers Prev 20 1 2011 112 122 10.1158/1055-9965.EPI-10-0944
11. J.S. Mandelblatt, K.A. Cronin, and S. Bailey Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms Ann Intern Med 151 10 2009 738 747 10.7326/0003-4819-151-10-200911170-00010
12. N.T. van Ravesteyn, D.L. Miglioretti, and N.K. Stout Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk Ann Intern Med 156 9 2012 609 617 10.7326/0003-4819-156-9-201205010-00002
13. C.R. Eheman, V.B. Benard, and D. Blackman Breast cancer screening among low-income or uninsured women: results from the National Breast and Cervical Cancer Early Detection Program, July 1995 to March 2002 (United States) Cancer Causes Control 17 1 2006 29 38 10.1007/s10552-005-4558-y
14. C. Desantis, R. Siegel, P. Bandi, and A. Jemal Breast cancer statistics, 2011 CA Cancer J Clin 61 6 2011 409 418 10.3322/caac.20134
15. S. Carter, S. Gartner, M. Haines, A. Olmstead, R. Stuch, and G. Wright Historical Statistics of the United States 2006 Cambridge Universiy Press New York
16. D.P. Smith, and B.S. Bradshaw Rethinking the Hispanic paradox: death rates and life expectancy for U.S. non-Hispanic White and Hispanic populations Am J Public Health 96 9 2006 1686 1692 10.2105/AJPH.2003.035378
17. T.R. Holford, K.A. Cronin, A.B. Mariotto, and E.J. Feuer Changing patterns in breast cancer incidence trends J Natl Cancer Inst Monogr 36 2006 19 25 10.1093/jncimonographs/lgj016
18. C.I. Li, K.E. Malone, and J.R. Daling Differences in breast cancer stage, treatment, and survival by race and ethnicity Arch Intern Med 163 1 2003 49 56 10.1001/archinte.163.1.49
19. K.S. Gill, and B.C. Yankaskas Screening mammography performance and cancer detection among black women and white women in community practice Cancer 100 1 2004 139 148 10.1002/cncr.11878
20. Early Breast Cancer Trialists Collaborative Group Polychemotherapy for early breast cancer: an overview of the randomised trials Lancet 352 9132 1998 930 942 10.1016/S0140-6736(98)03301-7
21. Early Breast Cancer Trialists Collaborative Group Tamoxifen for early breast cancer: an overview of the randomised trials Lancet 351 9114 1998 1451 1467 10.1016/S0140-6736(97)11423-4
22. Early Breast Cancer Trialists Collaborative Group Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 9472 2005 1687 1717 10.1016/S0140-6736(05)66544-0
23. J. Melnikow, D.J. Tancredi, and Z. Yang Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program Value Health 16 6 2013 932 941 10.1016/j.jval.2013.06.013
24. J.T. Schousboe, K. Kerlikowske, A. Loh, and S.R. Cummings Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness Ann Intern Med 155 1 2011 10 20 10.7326/0003-4819-155-1-201107050-00003
25. L.M. Henderson, R.A. Hubbard, and T.L. Onega Assessing health care use and cost consequences of a new screening modality: the case of digital mammography Med Care 50 12 2012 1045 1052 10.1097/MLR.0b013e318269e0d1
26. U.S. Preventive Services Task Force Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 151 10 2009 716 726 10.7326/0003-4819-151-10-200911170-00008 (W-236)
27. A.R. Levy, B.K. Bruen, and L. Ku Health care reform and womens insurance coverage for breast and cervical cancer screening Prev Chronic Dis 9 2012 E159 10.5888/pcd9.120069
28. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. Bethesda, MD: National Cancer Institute; seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013
29. R. Smith-Bindman, P.W. Chu, and D.L. Miglioretti Comparison of screening mammography in the United States and the United Kingdom JAMA 290 16 2003 2129 2137 10.1001/jama.290.16.2129
30. N. Coburn, J. Fulton, D.N. Pearlman, C. Law, B. DiPaolo, and B. Cady Treatment variation by insurance status for breast cancer patients Breast J 14 2 2008 128 134 10.1111/j.1524-4741.2007.00542.x
31. L.C. Richardson, J. Royalty, W. Howe, W. Helsel, W. Kammerer, and V.B. Benard Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detection Program, 1996-2005 Am J Public Health 100 9 2010 1769 1776 10.2105/AJPH.2009.160184
32. A.Y. El-Bastawissi, E. White, M.T. Mandelson, and S. Taplin Variation in mammographic breast density by race Ann Epidemiol 11 4 2001 257 263 10.1016/S1047-2797(00)00225-8
33. A.M. Bluekens, N. Karssemeijer, and D. Beijerinck Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates Eur Radiol 20 9 2010 2067 2073 10.1007/s00330-010-1786-7
34. S. Hofvind, P. Skaane, J.G. Elmore, S. Sebuodegard, S.R. Hoff, and C.I. Lee Mammographic performance in a population-based screening program: before, during, and after the transition from screen-film to full-field digital mammography Radiology 272 1 2014 52 62 10.1148/radiol.14131502